Gossamer Bio, Inc.
GOSS· Nasdaq
GOSSGossamer Bio, Inc.
Filed Mar 17, 2023 · 10-K · 76 days after period end · 0001728117-23-000010
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019 |
|---|---|---|---|---|
| Net Income | -$55.76M | -$56.28M | -$64.60M | -$54.70M |
| EPS Diluted | — | — | — | -$0.89 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gossamer Bio, Inc. · CIK 1728117 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Mar 17, 2023 · 76 d after period end
